Avapro and Cozaar are now the first drugs APPROVED for kidney disease in patients with type 2 diabetes and hypertension
October 2002
Avapro and Cozaar are now the first drugs APPROVED for kidney disease in patients with type 2 diabetes and hypertension.
For years ACE inhibitors were preferred for these patients. But no ACE inhibitor is actually APPROVED for this use.
Avapro (irbesartan) and Cozaar (losartan) slow progression of kidney disease...similar to ACE inhibitors. Other angiotensin receptor blockers probably work too.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote